Sleep Disorder Treatment Drug Market Size to Worth Around USD 29.1 Billion by 2027
Acumen Research and Consulting has announced the addition of the “Sleep Disorder Treatment Drug Market” report to their offering.
The Sleep Disorder Treatment Drug Market Industry Report 2030 is an in depth study analyzing the current state of the Sleep Disorder Treatment Drug Market. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Sleep Disorder Treatment Drug Market provides analysis of China market covering the industry trends, recent developments in the market and competitive landscape. Competitive analysis includes competitive information of leading players in China market, their company profiles, product portfolio, capacity, production, and company financials. In addition, report also provides upstream raw material analysis and downstream demand analysis along with the key development trends and sales channel analysis. Research study on Sleep Disorder Treatment Drug Market also discusses the opportunity areas for investors.
Download Sample Report Copy From Here:https://www.acumenresearchandconsulting.com/request-sample/2272
The report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
The players profiled in the report are GlaxoSmithKline plc, Koninklijke Philips N.V., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Cardinal Health, Pfizer Inc, Sanofi, Merck & Co Inc, Becton Dickson and Company, and Natus Medical Incorporated.
Market Segmentation:
Market By Drug Class
Sedative-hypnotics
Benzodiazepines
Dual orexin receptor antagonists
Melatonin receptor agonists
Antidepressants
Others
Market By Application
Intrinsic sleep disorders
- Psychophysiological insomnia
- Narcolepsy
- Restless legs syndrome
- Obstructive sleep apnea syndrome
- Others
Extrinsic sleep disorders
- Environmental sleep disorder
- Food allergy insomnia
- Toxin-induced sleep disorder
- Others
Market By Distribution Channel
Retail pharmacies
Online platforms
Others
Table Of Contents:
CHAPTER 1. Industry Overview of Sleep Disorders Treatment Drugs
1.1. Definition and Scope
1.1.1. Definition of Sleep Disorders Treatment Drugs
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Sleep Disorders Treatment Drugs Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Sleep Disorders Treatment Drugs Market By Drug Class
1.2.3. Sleep Disorders Treatment Drugs Market By Application
1.2.4. Sleep Disorders Treatment Drugs Market By Distribution Channel
1.2.5. Sleep Disorders Treatment Drugs Market by Regions
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Sleep Disorders Treatment Drugs Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Sleep Disorders Treatment Drugs Market
3.7. Value Chain Analysis
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2019
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Sleep Disorders Treatment Drugs Market By Drug Class
4.1. Introduction
4.2. Sleep Disorders Treatment Drugs Revenue By Drug Class
4.2.1. Sleep Disorders Treatment Drugs Revenue (US$ Mn) and Forecast, By Drug Class, 2016-2027
4.2.2. Sedative-hypnotics
4.2.2.1. Sedative-hypnotics Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.3. Benzodiazepines
4.2.3.1. Benzodiazepines Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.4. Dual orexin receptor antagonists
4.2.4.1. Dual orexin receptor antagonists Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.5. Melatonin receptor agonists
4.2.5.1. Melatonin receptor agonists Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.6. Antidepressants
4.2.6.1. Antidepressants Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.7. Others
4.2.7.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 5. Sleep Disorders Treatment Drugs Market Revenue By Application
5.1. Introduction
5.2. Sleep Disorders Treatment Drugs Revenue (US$ Mn) By Application
5.2.1. Sleep Disorders Treatment Drugs Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
5.2.2. Intrinsic sleep disorders
5.2.2.1. Intrinsic sleep disorders Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.2.2. Psychophysiological insomnia
5.2.2.3. Narcolepsy
5.2.2.4. Restless legs syndrome
5.2.2.5. Obstructive sleep apnea syndrome
5.2.2.6. Others
5.2.3. Extrinsic sleep disorders
5.2.3.1. Extrinsic sleep disorders Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3.2. Environmental sleep disorder
5.2.3.3. Food allergy insomnia
5.2.3.4. Toxin-induced sleep disorder
5.2.3.5. Others
CHAPTER 6. Sleep Disorders Treatment Drugs Market By Distribution Channel
6.1. Introduction
6.2. Sleep Disorders Treatment Drugs Revenue (US$ Mn) By Distribution Channel
6.2.1. Sleep Disorders Treatment Drugs Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
6.2.2. Retail pharmacies
6.2.2.1. Retail pharmacies Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.3. Online platforms
6.2.3.1. Online platforms Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.4. Others
6.2.4.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 7. North America Sleep Disorders Treatment Drugs Market By Country
7.1. North America Sleep Disorders Treatment Drugs Overview
7.2. U.S.
7.2.1. U.S. Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027
7.2.2. U.S. Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
7.2.3. U.S. Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
7.3. Canada
7.3.1. Canada Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027
7.3.2. Canada Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
7.3.3. Canada Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
7.4. North America PEST Analysis
CHAPTER 8. Europe Sleep Disorders Treatment Drugs Market By Country
8.1. Europe Sleep Disorders Treatment Drugs Market Overview
8.2. U.K.
8.2.1. U.K. Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027
8.2.2. U.K. Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.2.3. U.K. Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
8.3. Germany
8.3.1. Germany Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027
8.3.2. Germany Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.3.3. Germany Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
8.4. France
8.4.1. France Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027
8.4.2. France Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.4.3. France Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
8.5. Spain
8.5.1. Spain Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027
8.5.2. Spain Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.5.3. Spain Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
8.6. Rest of Europe
8.6.1. Rest of Europe Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027
8.6.2. Rest of Europe Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.6.3. Rest of Europe Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
8.7. Europe PEST Analysis
CHAPTER 9. Asia Pacific Sleep Disorders Treatment Drugs Market By Country
9.1. Asia Pacific Sleep Disorders Treatment Drugs Market Overview
9.2. China
9.2.1. China Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 – 2027
9.2.2. China Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
9.2.3. China Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
9.3. Japan
9.3.1. Japan Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 – 2027
9.3.2. Japan Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
9.3.3. Japan Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
9.4. India
9.4.1. India Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 – 2027
9.4.2. India Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
9.4.3. India Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
9.5. Australia
9.5.1. Australia Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 – 2027
9.5.2. Australia Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
9.5.3. Australia Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
9.6. South Korea
9.6.1. South Korea Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 – 2027
9.6.2. South Korea Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
9.6.3. South Korea Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 – 2027
9.7.2. Rest of Asia-Pacific Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
9.7.3. Rest of Asia-Pacific Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
9.8. Asia Pacific PEST Analysis
CHAPTER 10. Latin America Sleep Disorders Treatment Drugs Market By Country
10.1. Latin America Sleep Disorders Treatment Drugs Market Overview
10.2. Brazil
10.2.1. Brazil Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 – 2027
10.2.2. Brazil Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
10.2.3. Brazil Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
10.3. Mexico
10.3.1. Mexico Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 – 2027
10.3.2. Mexico Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
10.3.3. Mexico Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
10.4. Rest of Latin America
10.4.1. Rest of Latin America Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 – 2027
10.4.2. Rest of Latin America Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
CHAPTER 11. Middle East & Africa Sleep Disorders Treatment Drugs Market By Country
11.1. Middle East & Africa Sleep Disorders Treatment Drugs Market Overview
11.2. Saudi Arabia
11.2.1. Saudi Arabia Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 – 2027
11.2.2. Saudi Arabia Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
11.2.3. Saudi Arabia Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
11.3. UAE
11.3.1. UAE Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 – 2027
11.3.2. UAE Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
11.3.3. UAE Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & Africa Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 – 2027
11.4.2. Rest of Middle East & Africa Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
11.4.3. Rest of Middle East & Africa Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
CHAPTER 12. Player Analysis Of Sleep Disorders Treatment Drugs
12.1. Sleep Disorders Treatment Drugs Market Company Share Analysis
12.2. Competition Matrix
12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
12.2.2. New Product Launches and Product Enhancements
12.2.3. Mergers And Acquisition In Global Sleep Disorders Treatment Drugs Market
CHAPTER 13. Company Profile
13.1. GlaxoSmithKline plc
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (US$ Mn), 2019
13.1.3.2. PSC Biotech 2019 Sleep Disorders Treatment Drugs Business Regional Distribution
13.1.4. Product/ Service and Specification
13.1.5. Recent Developments & Business Strategy
13.1.6. Manufacturing Plant Footprint Analysis
13.2. Koninklijke Philips N.V.
13.3. Takeda Pharmaceutical Company Limited
13.4. Teva Pharmaceutical Industries Ltd.
13.5. Cardinal Health
13.6. Pfizer Inc
13.7. Sanofi
13.8. Merck & Co Inc
13.9. Becton Dickson and Company
13.10. Natus Medical Incorporated
13.11. Others
Ask Query Here: Richard@acumenresearchandconsulting.com or sales@acumenresearchandconsulting.com
To Purchase this Premium Report@https://www.acumenresearchandconsulting.com/buy-now/0/2272
About Us:
Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.
